87trades (@87_trades) profile picture
Joined December 2022
Photo by 87trades (@87_trades)Photo by 87trades (@87_trades)Photo by 87trades (@87_trades)Photo by 87trades (@87_trades)Photo by 87trades (@87_trades)Photo by 87trades (@87_trades)Photo by 87trades (@87_trades)Photo by 87trades (@87_trades)Photo by 87trades (@87_trades)Photo by 87trades (@87_trades)
$ADGM This is a key factor for anticipating a PMA decision before year end. @AdagioMedical worked with FDA on a modular approach, with clinical data being the final part submitted. FDA is aiming for 90% of PMA approval to be done in 180 days. We are right in the window for news.
62
$adgm I turned $4k into $500k in a year and half. Then gave it all back on this stock. I did all the things I knew I shouldn’t do but believed I was making an outsized, informed decision with significant upside. I mentally had a stop loss but when the time came I didn’t act.
1
3
385
$adgm tldr: this could result in a 100+% gain from here. Or it could crater because they can’t find a buyer. Note holders are providing cash. It’s sell, re-capitalize, or be liquidated. It’s still a 500k micro-cap stock. I’ve for a firm stop loss now and will see how it unfolds
2
108
Personally, while I’m pretty mad at myself, I know this is a hard lesson and a mistake I wont make again. On to the next stock. Thanks for coming to my therapy session.
2
2
61
$aent digitalmusicnews.com/2026/11… CEO Jeff Walker revealed that Alliance Entertainment is conducting a 14-store test with Best Buy, featuring vinyl records and CDs. Walker anticipates that the test will succeed and says it could expand to between 100 and 300 stores in 2027.
1
2
177
$aent 13 store pilot with @BestBuy for vinyl/CDs. Possible broader layout in new year. Physical music making a comeback!
86
$beat sold shares in .60s through ATM in early October (5.6 mil shared for $4 mil) Catalysts in q4 Planning to regain $1 compliance organically Will be interesting to watch
327
$adgm short term perspective. I don’t think anything is happening in next week. They will get compliance back for stock price then expect offering or deal. $400k float. PMA pending. Company seeking a sell. Let’s see what happens. Look for 10q on Friday.
1
190
$adgm two options are ahead of Adagio: 1) offering to give runway for PMA approval & next gen trial results & time to work deal 2) Some type of structured deal that involves reworking their senior notes Question: who wants their technology & what’s it worth? IMO>$1.5 mil!
136
$adgm I’ll moderate my comments a bit: I think they are working towards some type of deal, capital restructuring/reverse merger. I presume some type of offering is involved. Bottom line is that this vote isn’t until Dec. What happens in between?
$adgm I’ve never seen a company ask for a 1/300 reverse split. Do a 1/30 reverse split. And then the day after it takes an effect, ask for a 1/1000 reverse split. ALL THE WHILE THE COMPANY HAS NEVER ACTUALLY ISSUED ANY SHARES. 900k float. Asking for 1/1000 split. 😭🫠
132
$adgm 9/23 - 22 mil shares 10/1 - 27 mil shares 10/23 - Approve 1/10-1/300 r/s 11/9 - Do a 1/30 reverse split (900k shares 11/11 - Ask for a r/s up to 1/1000 They could announce bankruptcy & give stock a better chance to recover some value than their actions @AdagioMedical
168
$adgm I’ve never seen a company ask for a 1/300 reverse split. Do a 1/30 reverse split. And then the day after it takes an effect, ask for a 1/1000 reverse split. ALL THE WHILE THE COMPANY HAS NEVER ACTUALLY ISSUED ANY SHARES. 900k float. Asking for 1/1000 split. 😭🫠
1
2
279
$adgm using original PMA submission for PFA devices for AF, this is when you could expect Adagio’s PMA approval.
167
$adgm something interesting about this company. At every point they have signaled worse case and then delivered better than anticipated outcome. Lowered conversion of convertible notes to 85% of 5 day VWAP from 9/23-10/31 > they only converted $700k for 5 mil shares
1
1
1
329
Asked for r/s approval of up to 1/500 > did a r/s for 1/30 Announced strategic review without a word about next gen trial > announced today it’s enrolled 20 people (55 patient trial) They are currently still priced for worse case scenario! $adgm
1
1
205